Mary-Elizabeth Percival, MD

Dr. Mary-Elizabeth Percival MD
faculty member

Mary-Elizabeth Percival, MD

Associate Professor
Clinical Research Division, Fred Hutch

Fax: 206.606.2049
Mail Stop: CE3-300

Dr. Mary-Elizabeth Percival is a hematologic oncologist who specializes in the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome, which is a group of diseases that affect blood-cell formation. Her research focuses on the development of early phase clinical trials for patients with AML to test the effectiveness of new drugs and new combinations of drugs. Dr. Percival is also interested in epidemiological research to better understand the factors that affect survival and outcomes for AML patients. She practices at Fred Hutchinson Cancer Center and UW Medicine.

Other Appointments & Affiliations

Associate Professor, Division of Hematology and Oncology
University of Washington School of Medicine

Attending Physician
Fred Hutchinson Cancer Center


MS, Stanford University, 2016

MD, Stanford University, 2007

BA, Biochemical Sciences, Harvard University, 2000

Find a Clinical Trial

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email or call 206.667.2210